Women are told to improve their lifestyle to prevent heart disease while men are advised to take statins. That’s the finding of a study presented at ESC Asia scientific congress on 3 December. [1]
Siemens Healthineers presented its two latest magnetic resonance tomographs designed for clinical and scientific use at the Siemens Healthineers Shape 23 Keynote in November. The annual event offers a blend of market expertise and Siemens Healthineers innovations, which in some cases are unveiled for the first time at the event.
The U.S Food and Drug Administration’s (FDA) recent approval of Gadopiclenol injection, a gadolinium-based contrast agent (GBCA) for magnetic resonance imaging (MRI), paves the way for a new marketing paradigm that is designed to ensure the broadest possible access to patients and their healthcare professionals in need of imaging agents.
Wolters Kluwer, Health, a leading global provider of information and point of care solutions for the healthcare industry has announced the integration of BioDigital XR with Wolters Kluwer Medical Education & Medical Practice expansion. This collaboration will bring extended reality (XR) based medical education solutions to students across the healthcare landscape to enhance their curriculum, […]
HistoSonics, the developer of a non-invasive, novel sonic beam therapy, has raised $85 million in a financing led by Johnson & Johnson Innovation, to support its anticipated commercial launch, additional clinical trials, and to expand application development of Edison, the company’s novel histotripsy therapy platform, throughout the body.
Eurosets, a company based in Medolla, Italy and a leader in the development, production and commercialization of advanced medical devices, announced that the first patient has been treated with Colibrì, the lightest extracorporeal life support (ECLS) system available in the market.
FLEXcon Company, an innovator in adhesive coating and lami-nating, has initiated the commercialization of FLEXcon OMNI-WAVE Signal Receptive Media Components, a revolutionary biosensing technology that eliminates the need for hydrogel in medical diagnostic and therapeutic wearable devices.
SpineX, a clinical stage medtech company has published the groundbreaking results its first in human study [1] in children with cerebral palsy. The study, published in Nature Communications, demonstrates unparalleled functional improvements with its proprietary non-surgical treatment SCiP (Spinal Cord Innovation in Pediatrics) in children with Cerebral Palsy (CP).
It is widely held that “time is money” to highlight the important role efficiency can play in a business when it comes to making a profit or creating value. Similarly, we can all concede that “time is life” in the healthcare industry as doctors and nurses in the hospital race against time every day to […]
At the MEDICA trade fair to be held in Dusseldorf, Germany from 14-17 November, apart from the new products of the more than 4,200 participants from about 70 countries, the MEDICA HEALTH IT FORUM, an integrated part of the trade fair, will offer an overview of top trends in data-driven medicine.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.